Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., . . . Wijsenbeek, M. S. (2023). Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: The ISABELA 1 and 2 randomized clinical trials. The journal of the American Medical Association, 329(18), . https://doi.org/10.1001/jama.2023.5355
Chicago-Zitierstil (17. Ausg.)Maher, Toby M., et al. "Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials." The Journal of the American Medical Association 329, no. 18 (2023). https://doi.org/10.1001/jama.2023.5355.
MLA-Zitierstil (9. Ausg.)Maher, Toby M., et al. "Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials." The Journal of the American Medical Association, vol. 329, no. 18, 2023, https://doi.org/10.1001/jama.2023.5355.